Xencor, Inc. (XNCR) Key Metrics

NASDAQ: XNCRValuation, returns, debt and efficiency ratios over 10 years.

XNCR valuation today

Trailing 12 months · as of October 18, 2026
Market cap
$1.70B
Enterprise value
$1.52B
P/E (TTM)
—
10-yr median 47.2
Forward P/E
68.0
PEG ratio
—
Price / sales
16.2
10-yr median 12.8
Price / book
3.6
10-yr median 3.3
EV / EBITDA
—
10-yr median 41.5
Dividend yield
—
Beta
0.90

XNCR key metrics, 2016–2025

Fiscal year ended December 31, 2025 · U.S. dollars

XNCR valuation Price multiples at each fiscal year-end price.

Price / sales−33.1%
9.1
2025 · hover or tap a bar for each year
2016: 12.7 (−38.0%)2017: 28.7 (+125.4%)2018: 48.0 (+67.2%)2019: 12.8 (−73.3%)2020: 20.3 (+58.6%)2021: 8.8 (−56.6%)2022: 9.4 (+7.0%)2023: 7.6 (−19.2%)2024: 13.5 (+77.3%)2025: 9.1 (−33.1%)
20162025
Price / book−18.9%
1.8
2025 · hover or tap a bar for each year
2016: 3.6 (+1.2%)2017: 3.6 (+2.4%)2018: 3.7 (+2.8%)2019: 3.4 (−9.3%)2020: 4.4 (+28.6%)2021: 3.3 (−24.1%)2022: 2.1 (−35.5%)2023: 1.9 (−10.1%)2024: 2.2 (+14.9%)2025: 1.8 (−18.9%)
20162025
Free cash flow yield+1.8 pts
−12.2%
2025 · hover or tap a bar for each year
2016: 8.2% (+4.2 pts)2017: −4.0% (−12.2 pts)2018: −4.6% (−0.6 pts)2019: 2.7% (+7.2 pts)2020: −0.8% (−3.4 pts)2021: −1.4% (−0.6 pts)2022: −1.2% (+0.1 pts)2023: 5.0% (+6.2 pts)2024: −13.9% (−18.9 pts)2025: −12.2% (+1.8 pts)
20162025

XNCR valuation history

Fiscal year-endToday10-year median

XNCR returns on capital

ROEROICROA

Net income (ROE, ROA) or after-tax operating income (ROIC) divided by the average of the opening and closing balance.

XNCR debt vs cash

Total debtCash & short-term investments

Debt includes short- and long-term borrowings and, where reported, lease liabilities.

XNCR price vs earnings per share

Share price at year-endEPS (right axis)

XNCR key metrics

2016–2025
Xencor, Inc. key metrics by fiscal year
2025202420232022202120202019201820172016
Valuation
Market capitalization$1.14B$1.49B$1.28B$1.55B$2.43B$2.50B$2.01B$1.95B$1.03B$1.12B
Enterprise value$776.6M$1.23B$774.2M$989.9M$2.13B$1.90B$1.49B$1.67B$807.6M$992.2M
P/E ratio————29.4—74.8——47.2
Price / sales9.113.57.69.48.820.312.848.028.712.7
Price / book1.82.21.92.13.34.43.43.73.63.6
Price / free cash flow——20.1———37.7——12.2
Price / operating cash flow——15.163.4——31.2——11.8
EV / sales6.211.14.66.07.715.59.541.022.611.3
EV / EBITDA————41.5—82.5——41.3
EV / free cash flow——12.1———28.0——10.8
Earnings yield−8.1%−15.6%−9.8%−3.6%3.4%−2.5%1.3%−3.6%−4.8%2.1%
Free cash flow yield−12.2%−13.9%5.0%−1.2%−1.4%−0.8%2.7%−4.6%−4.0%8.2%
Dividend yield————————0.0%0.0%
Shareholder yield (dividends + buybacks)0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%
Share price at fiscal year-end$15.31$22.98$21.23$26.04$40.12$43.63$34.39$36.16$21.92$26.32
Per share
Revenue per share$1.69$1.70$2.78$2.76$4.55$2.14$2.68$0.75$0.76$2.06
Earnings per share−$1.24−$3.58−$2.08−$0.93$1.37−$1.11$0.46−$1.31−$1.05$0.56
Operating cash flow per share−$1.82−$3.11$1.41$0.41−$0.28−$0.09$1.10−$1.48−$0.72$2.23
Free cash flow per share−$1.86−$3.20$1.06−$0.32−$0.54−$0.33$0.91−$1.65−$0.87$2.16
Cash per share$7.38$7.65$9.81$10.44$5.52$10.54$9.01$5.46$4.79$3.07
Book value per share$8.56$10.42$11.06$12.20$12.12$10.01$10.15$9.67$6.02$7.41
Tangible book value per share$8.45$10.13$10.75$11.89$11.85$9.73$9.90$9.45$5.79$7.16
Dividends per share————————$0.00$0.00
Capex per share$0.04$0.09$0.35$0.73$0.26$0.24$0.19$0.17$0.16$0.07
Debt per share$2.53$3.57$1.38$1.00$0.56$0.20$0.18$0.18$0.12$0.16
Shares outstanding74.2M65.0M60.5M59.7M60.5M57.2M58.5M53.9M46.8M42.4M
Change in shares outstanding+14.1%+7.5%+1.4%−1.4%+5.7%−2.1%+8.4%+15.2%+10.4%+8.6%
Returns & profitability
Return on equity (ROE)−14.0%−34.5%−18.1%−7.6%12.7%−10.9%4.8%−17.5%−16.4%9.9%
Return on invested capital (ROIC)−40.8%−49.4%−67.8%−21.8%21.1%—8.7%−41.7%−33.3%16.9%
Return on assets (ROA)−10.1%−24.4%−14.0%−6.6%10.7%−9.3%4.3%−14.6%−12.0%7.4%
Return on tangible assets−10.6%−24.9%−13.5%−6.7%10.1%−9.2%4.1%−12.5%−12.9%5.6%
Free cash flow margin−110.1%−188.5%37.9%−11.5%−11.9%−15.3%34.0%−219.0%−114.7%104.7%
Income quality (OCF / net income)————−0.20—2.40——4.00
Financial health
Total debt$187.7M$232.0M$83.4M$59.6M$34.0M$11.6M$10.7M$9.7M$5.5M$6.7M
Cash & short-term investments$547.7M$497.8M$593.7M$623.1M$334.1M$603.0M$527.1M$294.4M$224.1M$130.1M
Net debt−$360.0M−$265.8M−$510.3M−$563.4M−$300.1M−$591.4M−$516.3M−$284.7M−$218.7M−$123.4M
Debt / equity0.300.340.120.080.050.020.020.020.020.02
Debt / assets0.210.240.090.070.040.020.020.020.010.02
Net debt / EBITDA————−5.86—−28.49——−5.14
Current ratio6.256.617.3610.586.005.278.395.862.281.33
Quick ratio6.256.617.4910.586.525.278.395.862.281.33
Interest coverage-5.6-4.9-22.4-2.25.8—0.8———
Working capital$503.9M$490.2M$538.5M$611.5M$353.6M$516.6M$491.8M$261.9M$129.5M$35.4M
Invested capital$275.6M$411.8M$158.8M$164.1M$433.4M−$18.9M$76.9M$237.0M$63.4M$190.5M
Tangible asset value$627.2M$655.5M$650.5M$709.0M$717.0M$556.5M$578.8M$509.7M$270.9M$303.6M
Net current asset value$359.9M$299.7M$339.6M$556.6M$319.7M$506.9M$481.4M$260.7M$122.8M$27.0M
Graham number————$19.30—$10.24——$9.64
Graham net-net per share$4.44$4.08$5.17$8.82$4.31$8.57$8.01$4.58$2.50$0.52
Capital allocation
Dividends paid————————$0$0
Share buybacks (net)$0$0$0$0$0$0$0$0$0$0
Dividend payout ratio—————————0.0%
Dividends + buybacks / free cash flow——0.0%———0.0%——0.0%
Capex / revenue2.5%5.5%12.6%26.4%5.8%11.2%7.0%22.5%20.4%3.4%
Capex / operating cash flow——25.0%177.3%——17.1%——3.2%
Capex / depreciation0.300.501.854.932.132.382.572.813.592.05
Stock-based compensation / revenue34.4%48.2%31.9%29.7%13.4%25.8%20.3%50.6%38.2%9.0%
R&D / revenue190.7%206.1%150.6%121.3%70.0%138.4%75.7%240.1%201.0%59.3%
SG&A / revenue50.7%45.3%31.7%28.9%15.7%24.2%15.5%55.3%49.0%15.0%
Efficiency
Days sales outstanding131.0119.243.7105.859.972.540.750.949.918.1
Days of inventory on hand——-8.1-764.5-1,796.0—0.00.00.0-0.2
Days payables outstanding478.924.617.3499.6559.220.621.520.027.336.2
Cash conversion cycle (days)-347.994.618.3-1,158.4-2,295.351.919.231.022.5-18.3
Receivables turnover2.793.068.363.456.095.048.967.177.3220.21
Payables turnover0.7614.8521.130.730.6517.7416.9618.2813.3510.09
Inventory turnover——————118,590,000.0097,501,000.0071,772,000.00—
Asset turnover0.140.120.190.200.360.180.250.080.090.28
Average receivables$45.1M$36.1M$20.1M$47.7M$45.2M$24.4M$17.5M$5.7M$4.9M$4.3M
Average payables$13.8M$15.3M$12.0M$12.0M$11.5M$9.6M$7.0M$5.3M$5.4M$5.1M
Average inventory——−$5.6M−$18.4M−$36.9M—$1$1$1−$22,000
Intangibles / total assets1.0%1.9%2.0%2.2%2.0%2.3%2.2%2.1%2.9%2.4%

Computed from XNCR's annual financial statements (latest annual report filed February 25, 2026) and the closing share price on each fiscal year-end, adjusted for stock splits. Figures in U.S. dollars; data from EODHD. Averages use the opening and closing balance of each year.

XNCR valuation and financial ratios

Xencor earned a return on equity of −14.0% and a return on invested capital of −40.8% in fiscal 2025. It ended the year with $187.7 million of debt and $547.7 million in cash and short-term investments, a net cash position of $360.0 million. The share count rose 75.1% from 42.4M to 74.2M over 9 years.

See the XNCR income statement, the XNCR chart for price history, or the XNCR stock overview for the latest quote and news.

XNCR key metrics FAQ

What is Xencor's return on equity?

Xencor's return on equity (ROE) was −14.0% in fiscal 2025: net income of -$91.9 million on average shareholders' equity of $656.6 million.

What is Xencor's ROIC?

Xencor's return on invested capital was −40.8% in fiscal 2025, using after-tax operating income divided by average debt plus equity minus cash.

How much debt does Xencor have?

Xencor had total debt of $187.7 million at the end of fiscal 2025, a debt-to-equity ratio of 0.30 and more cash than debt.

What is Xencor's free cash flow yield?

Xencor generated -$138.3 million of free cash flow in fiscal 2025, a free cash flow yield of −12.2% on its market value at year-end ($1.1 billion).

What is Xencor's current ratio?

Xencor's current ratio was 6.25 at the end of fiscal 2025: current assets were 6.25 times current liabilities.

Biotechnology key metrics